ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Lifecore Biomedical Inc

Lifecore Biomedical Inc (LFCR)

7.28
-0.21
(-2.80%)
終了 12月30日 6:00AM
7.28
0.00
(0.00%)
取引時間後: 6:00AM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

通貨
7.28
買値
7.08
売値
7.62
出来高
189,450
7.11 日の範囲 7.57
3.6793 52 週間の範囲 8.90
時価総額
前日終値
7.49
始値
7.40
時刻
2
@
7.13
最終取引時間
財務取引量
US$ 1,373,707
VWAP
7.251
平均取引量 (3 か月)
193,530
発行済株式数
30,898,255
配当利回り
-
PER
18.72
1 株当たり利益 (EPS)
0.39
歳入
128.26M
純利益
12.01M

Lifecore Biomedical Inc について

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hy... Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. 詳細を表示

セクター
Plastics,resins,elastomers
業界
Plastics,resins,elastomers
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Lifecore Biomedical Inc is listed in the Plastics,resins,elastomers sector of the ナスダック市場 with ticker LFCR. The last closing price for Lifecore Biomedical was US$7.49. Over the last year, Lifecore Biomedical shares have traded in a share price range of US$ 3.6793 to US$ 8.90.

Lifecore Biomedical currently has 30,898,255 shares in issue. The market capitalisation of Lifecore Biomedical is US$231.43 million. Lifecore Biomedical has a price to earnings ratio (PE ratio) of 18.72.

LFCR 最新ニュース

Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025

CHASKA, Minn., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...

Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment

Development Services Span Tech Transfer, Process Assessment and Method Validation for Fill and Finish of NRS-033 for Planned Phase 2 Trial Lifecore to Leverage Differentiated Capabilities and...

Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO

Three-Year Term Extension Combined with Simplification and Reduction of Interest Rates Helps Further Strengthen Company’s Balance Sheet and Overall Financial Position Builds Upon Other Recent...

Lifecore Biomedical Hosts Virtual Investor Day

CHASKA, Minn., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.233.262411347527.057.786.8953492217.32052331CS
4-0.25-3.320053120857.537.886.852040147.37320226CS
122.3748.26883910394.917.994.331935306.61861925CS
262.5353.26315789474.757.993.67932122425.64474972CS
520.8913.92801251966.398.93.67931993525.86864638CS
156-1.8-19.82378854639.0811.4551.523192395.87993711CS
260-1.8-19.82378854639.0811.4551.523192395.87993711CS

LFCR - Frequently Asked Questions (FAQ)

What is the current Lifecore Biomedical share price?
The current share price of Lifecore Biomedical is US$ 7.28
How many Lifecore Biomedical shares are in issue?
Lifecore Biomedical has 30,898,255 shares in issue
What is the market cap of Lifecore Biomedical?
The market capitalisation of Lifecore Biomedical is USD 231.43M
What is the 1 year trading range for Lifecore Biomedical share price?
Lifecore Biomedical has traded in the range of US$ 3.6793 to US$ 8.90 during the past year
What is the PE ratio of Lifecore Biomedical?
The price to earnings ratio of Lifecore Biomedical is 18.72
What is the cash to sales ratio of Lifecore Biomedical?
The cash to sales ratio of Lifecore Biomedical is 1.75
What is the reporting currency for Lifecore Biomedical?
Lifecore Biomedical reports financial results in USD
What is the latest annual turnover for Lifecore Biomedical?
The latest annual turnover of Lifecore Biomedical is USD 128.26M
What is the latest annual profit for Lifecore Biomedical?
The latest annual profit of Lifecore Biomedical is USD 12.01M
What is the registered address of Lifecore Biomedical?
The registered address for Lifecore Biomedical is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Lifecore Biomedical website address?
The website address for Lifecore Biomedical is www.lifecore.com
Which industry sector does Lifecore Biomedical operate in?
Lifecore Biomedical operates in the PLASTICS,RESINS,ELASTOMERS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
INTZIntrusion Inc
US$ 2.167
(381.56%)
189.59M
AILEiLearningEngines Inc
US$ 0.5932
(267.31%)
563.26M
HUBCWHub Cyber Security Ltd
US$ 0.035
(250.00%)
2.79M
GTIGraphjet Technology
US$ 0.967551
(185.83%)
398.95M
LITMSnow Lake Resources Ltd
US$ 1.61
(82.95%)
131.98M
NEUPNeuphoria Therapeutics Inc
US$ 4.11
(-92.30%)
936.47k
VIRXViracta Therapeutics Inc
US$ 0.16
(-32.49%)
9.31M
PRFXPainReform Ltd
US$ 3.48
(-28.98%)
926.19k
AIREreAlpha Tech Corporation
US$ 2.56
(-28.49%)
8.26M
AVGRAvinger Inc
US$ 0.9721
(-24.05%)
2.11M
AILEiLearningEngines Inc
US$ 0.5932
(267.31%)
563.26M
GTIGraphjet Technology
US$ 0.967551
(185.83%)
398.95M
RGTIRigetti Computing Inc
US$ 17.08
(10.62%)
305.79M
XTIAXTI Aerospace Inc
US$ 0.03935
(-1.63%)
268M
QSIQuantum Si Inc
US$ 3.585
(66.74%)
256.01M

最近閲覧した銘柄